Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuemei Zeng

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
The Analyst|July 13, 2023
On-chip-angiogenesis based on a high-throughput biomimetic three-dimensional cell spheroid culture systemYachao Wang, Xuemei Zeng, Peng Chen, et al.
Biochemical Genetics|July 29, 2008
Mitochondrial DNA diversity of Monopterus albus from the Sichuan Basin of ChinaXin Cai, Xingneng Gou, Fankun Zeng, et al.
Plos One|May 27, 2016
Threonine 89 Is an Important Residue of Profilin-1 That Is Phosphorylatable by Protein Kinase ADavid Gau, William Veon, Xuemei Zeng, et al.
Frontiers in Immunology|January 23, 2024
Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysisXiyuan Zhou, Ge Yang, Xuemei Zeng, et al.
Journal of Nanobiotechnology|November 20, 2025
Targeting cancer stem-like cells via cholesterol modulation and ferroptosis induction using a multifunctional nanoplatform to overcome drug resistanceLeiguang Ye, Jinying Zhu, Xiaoman Wang, et al.
Pathology, Research and Practice|September 18, 2022
Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancerXuemei Zeng, Juan Xiao, Xue Bai, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 21, 2023
Energy metabolism: a new target for gastric cancer treatmentJiangrong Liu, Xue Bai, Meilan Zhang, et al.
Molecular Genetics and Metabolism|April 28, 2004
Detection and assignment of CYP21 mutations using peptide mass signature genotypingXuemei Zeng, Selma F Witchel, Steven F Dobrowolski, et al.
ACS Applied Materials & Interfaces|February 20, 2020
"All-in-One" Silver Nanoprism Platform for Targeted Tumor TheranosticsXuemei Zeng, Shuangqian Yan, Chao Di, et al.
ACS Nano|September 4, 2025
Reprogramming Macrophage Function via Cholesterol Modulation and Redox Signaling Using a Multifunctional Nanoplatform for Postoperative Breast Cancer ManagementXuemei Zeng, Shumin Tang, Guosheng Hu, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
The Analyst|July 13, 2023
On-chip-angiogenesis based on a high-throughput biomimetic three-dimensional cell spheroid culture systemYachao Wang, Xuemei Zeng, Peng Chen, et al.
Biochemical Genetics|July 29, 2008
Mitochondrial DNA diversity of Monopterus albus from the Sichuan Basin of ChinaXin Cai, Xingneng Gou, Fankun Zeng, et al.
Plos One|May 27, 2016
Threonine 89 Is an Important Residue of Profilin-1 That Is Phosphorylatable by Protein Kinase ADavid Gau, William Veon, Xuemei Zeng, et al.
Frontiers in Immunology|January 23, 2024
Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysisXiyuan Zhou, Ge Yang, Xuemei Zeng, et al.
Journal of Nanobiotechnology|November 20, 2025
Targeting cancer stem-like cells via cholesterol modulation and ferroptosis induction using a multifunctional nanoplatform to overcome drug resistanceLeiguang Ye, Jinying Zhu, Xiaoman Wang, et al.
Pathology, Research and Practice|September 18, 2022
Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancerXuemei Zeng, Juan Xiao, Xue Bai, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 21, 2023
Energy metabolism: a new target for gastric cancer treatmentJiangrong Liu, Xue Bai, Meilan Zhang, et al.
Molecular Genetics and Metabolism|April 28, 2004
Detection and assignment of CYP21 mutations using peptide mass signature genotypingXuemei Zeng, Selma F Witchel, Steven F Dobrowolski, et al.
ACS Applied Materials & Interfaces|February 20, 2020
"All-in-One" Silver Nanoprism Platform for Targeted Tumor TheranosticsXuemei Zeng, Shuangqian Yan, Chao Di, et al.
ACS Nano|September 4, 2025
Reprogramming Macrophage Function via Cholesterol Modulation and Redox Signaling Using a Multifunctional Nanoplatform for Postoperative Breast Cancer ManagementXuemei Zeng, Shumin Tang, Guosheng Hu, et al.
Pageof 15